Updates on Our Science, Progress, and Global Mission

The Latest News at Aurion

Aurion Biotech is advancing breakthrough science, clinical progress, and organizational milestones in the development of globally available therapies for corneal endothelial disease. Explore the latest updates on our research, programs, collaborations, and regulatory progress.

March 11, 2026

Aurion Biotech Appoints World Renowned Cornea Surgeon Marjan Farid, M.D.,to Chair Medical Advisory Board

October 18, 2025

Aurion Biotech Achieves All Primary, Secondary, and Exploratory Endpoints in AURN001 Phase 1/2 CLARA Trial at 12 Months

September 30, 2025

Aurion Biotech Expands Leadership Team, Promoting Andrew Torres, Ph.D., to Chief Manufacturing Officer and Sterling Chung to Chief Regulatory & Quality Officer

April 22, 2025

Aurion Biotech Appoints Edward J. Holland, M.D., as Chief Medical Officer and Eris P. Jordan, O.D., as Chief Development Officer

Expanding the Reach of Every Donor Cornea

Aurion Biotech collaborates with clinicians, researchers, and partners committed to advancing the future of corneal treatments. Get in touch to learn more about our science, programs, and global mission.